BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients

BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients

SARS-CoV-2 vaccination is the standard of care for the prevention of COVID-19 disease. Although vaccination triggers both humoral and cellular immune response, COVID-19 vaccination efficacy is currently evaluated by measuring antibodies only, whereas adaptative cellular immunity is unexplored. Our a...

Full description

Bibliographic Details
Main Authors: Evelina La Civita, Carla Zannella, Stefano Brusa, Paolo Romano, Elisa Schettino, Fabrizio Salemi, Rosa Carrano, Luca Gentile, Alessandra Punziano, Gianluca Lagnese, Giuseppe Spadaro, Gianluigi Franci, Massimiliano Galdiero, Daniela Terracciano, Giuseppe Portella, Stefania Loffredo
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Viruses
Subjects:
mRNA vaccine
immunodeficiency
humoral immunity
cell-mediated immunity
Online Access:https://www.mdpi.com/1999-4915/15/8/1659

Internet

https://www.mdpi.com/1999-4915/15/8/1659

Similar Items